A multinational, multi-centre, observational, cross-sectional survey assessing diabetes secondary care in Central and Eastern Europe (DEPAC Survey)

Diabetic Medicine

Volumn 25, Issue 10, 2008, Pages 1195-1203

  Andel, M ^a   Grzeszczak, W ^b   Michalek, J ^c   Medvescek, M ^d   Norkus, A ^e   Rasa, I ^f   Niewada, M ^g   Kaminski B ^h   Kraml, P ^a   Madacsy, L ⁱ  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c National Institute of Endocrinology and Diabetology   (Slovakia)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^e KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^f Department of General and Cololateral Surgery   (Latvia)

^g MEDICAL UNIVERSITY OF WARSAW   (Poland)

^h WARSAW SCHOOL OF ECONOMICS   (Poland)

ⁱ SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Central and Eastern Europe; Cross sectional survey; Diabetes care

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLINDNESS; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PREVALENCE; QUESTIONNAIRE;

ADULT; AMBULATORY CARE; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; EUROPE, EASTERN; FEMALE; HEALTH CARE SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 53349128946     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02570.x     Document Type: Article

References (27)

1. The Diabetes Control Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 329 : 977 986.
2. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes UK Prospective Diabetes Study (UKPDS 35): prospective observational study. Br Med J 2000 321 : 405 412.
3. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R et al Professional Practice Committee, American Diabetes Association; European Association for the Study of Diabetes. Management of hyperglycaemia in Type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2006 49 : 1711 1721.
4. 1c. Available at http://www.ngsp.org/prog/ index.html Last accessed 9 July 2007.
5. Ilyes I, Jancso Z, Kovacs E, Marton H, Simay A. Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care. Orv Hetil 2005 146 : 2581 2588.
6. Fox KM, Gerber Pharmd RA, Bolinder B, Chen J, Kumar S. Prevalence of inadequate glycemic control among patients with Type 2 diabetes in the UK general practice research database: a series of retrospective analyses of data from 1998 through 2002. Clin Ther 2006 28 : 388 395.
7. Mainous AG III., Diaz VA, Saxena S, Baker R, Everett CJ, Koopman RJ et al. Diabetes management in the USA and England: comparative analysis of national surveys. J R Soc Med 2006 99 : 463 469.
8. Chowdhury TA, Lasker SS, Mahfuz R. Ethnic differences in control of cardiovascular risk factors in patients with Type 2 diabetes attending an inner London diabetes clinic. Postgrad Med J 2006 1982 : 211 215.
9. Diaz Gravalos GJ, Palmeiro Fernandez G, Casado Gorriz I, Arandia Garcia M, Portuburu Izaguirre MM, Vazquez Fernandez LA. Compliance with the metabolic goals in diabetes mellitus in the rural area of Ourense, Spain. Rev Esp Salud Publica 2006 80 : 67 75.
10. Eliasson B, Cederholm J, Nilsson P, Gudbjornsdottir S, Steering Committee of the Swedish National Diabetes Register. The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003. Diabet Med 2005 22 : 1420 1426.
11. Jorgensen LG, Petersen PH, Heickendorff L, Moller HJ, Hendel J, Christensen C et al. Glycaemic control in three Danish counties. Clin Chem Lab Med 2005 43 : 1366 1372.
12. Charpentier G, Genes N, Vaur L, Amar J, Clerson P, Cambou JP et al. Control of diabetes and cardiovascular risk factors in patients with Type 2 diabetes: a nationwide French survey. Diabetes Metab 2003 29 : 152 158.
13. Prevost G, Phan TM, Mounier-Vehier C, Fontaine P. Control of cardiovascular risk factors in patients with Type 2 diabetes and hypertension in a French national study (Phenomenon). Diabetes Metab 2005 31 : 479 485.
14. Comaschi M, Coscelli C, Cucinotta D, Malini P, Manzato E, Nicolucci A SFIDA Study Group - Italian Association of Diabetologists (AMD). Cardiovascular risk factors and metabolic control in Type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (Survey of Risk Factors in Italian Diabetic Subjects by AMD) study. Nutr Metab Cardiovasc Dis 2005 15 : 204 211.
15. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in Type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 2006 49 : 1761 1769.
16. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu RS, Colhoun HM, Lawrenson RA et al. Risk of stroke in people with Type 2 diabetes in UK: a study using the General Practice Research Database. Diabetologia 2006 49 : 2859 2865.
17. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. INTERHEART Study Investigators: effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 364 : 937 952.
18. Millett C, Dodhia H. Diabetes retinopathy screening: audit of equity in participation and selected outcomes in south-east London. J Med Screen 2006 13 : 152 155.
19. Guiffre G, Lodato G, Dardanoni G. Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects: the Casteldacchia Eye Study. Graefes Arch Clin Exp Ophthalmol 2004 242 : 535 540.
20. Hove MN, Kristensen JK, Lauritzen T, Bek T. The prevalence of retinopathy in an unselected population of Type 2 diabetes patients from Arhus County, Denmark. Acta Ophtalmol Scand 2004 82 : 443 448.
21. Henriksen OM, Roder ME, Prahl JB, Svendsen OL. Diabetic ketoacidosis in Denmark: incidence and mortality estimated from public health registries. Diabetes Res Clin Pract 2007 76 : 51 56.
22. Shaya FT, Shin JY, Mullins D, Fatodu HO, Gu A, Saunders E. Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin. J Natl Med Assoc 2005 97 : 493 497.
23. Langendam MW, Hooijkaas C, Piepenbrink JF. The increase in the use of drug treatment for diabetes mellitus in the Netherlands 1998-2003. Ned Tijdschr Geneeskd 2006 150 : 1396 1401.
24. Teeling M, Bennett K, Feely J. The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002. Br J Clin Pharmacol 2005 59 : 227 232.
25. Wandell PE, Brorsson B, Aberg H. Drug prescription in diabetic patients in 1992 and 1995 - change over time. Eur J Clin Pharmacol 1997 52 : 249 254.
26. Cooke CE, Fatodu H. Physician conformity and patients adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a Medicaid managed care organization. J Manag Care Pharm 2006 12 : 649 655.
27. Bryant W, Greenfield JR, Chisholm DJ, Campbell LV. Diabetes guidelines: easier to preach than to practise? Med J Aust 2006 185 : 305 309.